Published in J Med Genet on April 01, 2004
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J Med Genet (2005) 1.65
Refinement of the genetic cause of ATR-16. Hum Genet (2007) 0.97
A 4q35.2 subtelomeric deletion identified in a screen of patients with co-morbid psychiatric illness and mental retardation. BMC Med Genet (2004) 0.92
Subtelomeric FISH analysis in 76 patients with syndromic developmental delay/intellectual disability. Ital J Pediatr (2009) 0.87
PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1. Neurogenetics (2006) 0.80
A complex rearrangement on chromosome 22 affecting both homologues; haplo-insufficiency of the Cat eye syndrome region may have no clinical relevance. Hum Genet (2006) 0.80
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet (1998) 21.52
Recent segmental duplications in the human genome. Science (2002) 21.30
Allelic variation in human gene expression. Science (2002) 11.42
Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet (2001) 11.06
Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet (1998) 7.93
[Study of somatic chromosomes from 9 mongoloid children]. C R Hebd Seances Acad Sci (1959) 6.88
The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet (1995) 4.25
Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet (1999) 4.20
A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet (1999) 4.14
Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet (2001) 3.28
The end of the beginning of chromosome ends. Am J Med Genet (2002) 3.05
Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet (2003) 3.01
Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet (2003) 2.75
Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res (2000) 2.70
The complex structure and dynamic evolution of human subtelomeres. Nat Rev Genet (2002) 2.57
Telomeres: a diagnosis at the end of the chromosomes. J Med Genet (2003) 2.52
Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res (2003) 2.34
Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet (2003) 2.15
Interstitial and terminal deletions of the long arm of chromosome 4: further delineation of phenotypes. Am J Med Genet (1988) 2.00
Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. Am J Hum Genet (1990) 1.87
Congenital anomalies and anthropometry of 42 individuals with deletions of chromosome 18q. Am J Med Genet (1999) 1.76
Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype. Am J Med Genet (1999) 1.74
The use of telomere probes to investigate submicroscopic rearrangements associated with mental retardation. Curr Opin Genet Dev (2003) 1.64
Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet (2002) 1.55
Characterizing the physical genome. Nat Genet (2002) 1.35
DNA rearrangements on both homologues of chromosome 17 in a mildly delayed individual with a family history of autosomal dominant carpal tunnel syndrome. Am J Hum Genet (1999) 1.28
Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally? Mol Genet Metab (2003) 1.23
An infant with deletion of the distal long arm of chromosome 15 (q26.1----qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet (1991) 1.23
Partial deletion of chromosome 6p: delineation of the syndrome. Am J Med Genet (1991) 1.22
Screening for subtelomeric chromosome abnormalities in children with idiopathic mental retardation using multiprobe telomeric FISH and the new MAPH telomeric assay. Eur J Hum Genet (2001) 1.21
Extensive cross-homology between the long and the short arm of chromosome 16 may explain leukemic inversions and translocations. Blood (1992) 1.12
High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH). J Med Genet (2002) 1.12
Identification of cryptic rearrangements in patients with 18q- deletion syndrome. Am J Hum Genet (1998) 0.99
Distal deletion of the short arm of chromosome 6. Am J Med Genet (1990) 0.98
DiGeorge/velocardiofacial syndrome: FISH studies of chromosomes 22q11 and 10p14, and clinical reports on the proximal 22q11 deletion. Am J Med Genet A (2003) 0.96
Six cases of 7p deletion: clinical, cytogenetic, and molecular studies. Am J Med Genet (1994) 0.89
Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in the C1 inhibitor gene of hereditary angioedema patients. Hum Mutat (2001) 0.87
Molecular and clinical characterization of a patient with duplication of 1p36.3 and metopic synostosis. Clin Genet (1999) 0.86
Alagille syndrome in a family with duplication 20p11. Clin Dysmorphol (1996) 0.77
Cytogenetics study in severely mentally retarded patients. Saudi Med J (2001) 0.77
A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature (1985) 7.34
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (1995) 7.11
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet (1992) 5.12
Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet (1997) 4.95
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res (2000) 4.66
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet (1995) 3.61
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet (2008) 3.35
A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18
WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet (1998) 2.77
[Risk factors for structural chromosomal abnormality in > or = 2 miscarriages, as an instrument for selective karyotyping]. Ned Tijdschr Geneeskd (2007) 2.71
Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur J Med Genet (2009) 2.65
Conjunction dysfunction: CBP/p300 in human disease. Trends Genet (1998) 2.64
Rapid subchromosomal localization of cosmids by nonradioactive in situ hybridization. Cytogenet Cell Genet (1990) 2.60
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord (2011) 2.47
Statistical errors in papers in the British Journal of Psychiatry. Br J Psychiatry (1979) 2.38
The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett (2000) 2.24
Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet (1993) 2.08
Inadvertent esophageal intubation in the field: reliance on a fool's "gold standard". Acad Emerg Med (1997) 2.07
Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet (2005) 1.96
Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16. Br Med J (Clin Res Ed) (1986) 1.93
Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut (2007) 1.79
Human alpha-globin maps to pter-p13.3 in chromosome 16 distal to PGP. Hum Genet (1987) 1.76
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet (2001) 1.76
Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet (1997) 1.73
Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics (1997) 1.70
Mapping the short arm of human chromosome 16. Genomics (1989) 1.69
Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet (1996) 1.67
Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet (1997) 1.63
Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney Int (1999) 1.61
Duplications in the DMD gene. Hum Mutat (2006) 1.58
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol Dis (1999) 1.54
Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. Am J Med Genet A (2005) 1.54
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet (2001) 1.51
In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin. Antimicrob Agents Chemother (1984) 1.50
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR Am J Neuroradiol (1992) 1.49
Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker. Lancet (1991) 1.44
[From gene to disease; from hemoglobin genes to thalassemia and sickle cell anemia]. Ned Tijdschr Geneeskd (2000) 1.43
Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum Mol Genet (1996) 1.42
Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease. Nat Genet (1996) 1.40
The need for evaluation of gastroesophageal reflux in brain-damaged children referred for feeding gastrostomy. J Pediatr Surg (1981) 1.39
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet (2005) 1.38
Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet (2011) 1.38
De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet (2000) 1.37
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1997) 1.36
Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet (1998) 1.34
Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet (2007) 1.32
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Gene Ther (2004) 1.31
Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J (2005) 1.31
Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther (2004) 1.30
Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res (2006) 1.29
Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes. Am J Hum Genet (1995) 1.27
A study of genetic linkage heterogeneity in adult polycystic kidney disease. Hum Genet (1987) 1.27
Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet (1979) 1.27
Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations. J Med Genet (2000) 1.26
Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. J Am Soc Nephrol (1999) 1.26
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics (2005) 1.23
Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei. Biochem J (2001) 1.23
Strict co-linearity of genetic and protein folding domains in an intragenically duplicated rat lens gamma-crystallin gene. J Mol Biol (1983) 1.21
Relative power and sample size analysis on gene expression profiling data. BMC Genomics (2009) 1.21
Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet (1992) 1.21
Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet (2000) 1.20
Copy number variation and mosaicism. Cytogenet Genome Res (2009) 1.20
Structural variation in mammalian gamma-crystallins based on computer graphics analyses of human, rat and calf sequences. 1. Core packing and surface properties. Exp Eye Res (1986) 1.20
Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients. Neuromuscul Disord (2010) 1.19
Somatic origin of inherited haemophilia A. Hum Genet (1990) 1.19
Cellular localization and tissue distribution of polycystin-1. J Pathol (1999) 1.18
Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet (2009) 1.17
Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. J Pathol (2007) 1.17
Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2000) 1.17
Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects. Am J Hum Genet (1993) 1.16
Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3. Genomics (1997) 1.15
High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. Nucleic Acids Res (1989) 1.15
Concerted and divergent evolution within the rat gamma-crystallin gene family. J Mol Biol (1986) 1.13
Cerebral microbleeds in CADASIL. Neurology (2001) 1.13
Extensive cross-homology between the long and the short arm of chromosome 16 may explain leukemic inversions and translocations. Blood (1992) 1.12
Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3. Am J Hum Genet (1993) 1.12
Partial trisomy 6p due to familial translocation t(6;20)(p21;p13). A new syndrome? Hum Genet (1977) 1.12
An automatic registration method for frameless stereotaxy, image guided surgery, and enhanced reality visualization. IEEE Trans Med Imaging (1996) 1.11
Characterization of SCML1, a new gene in Xp22, with homology to developmental polycomb genes. Genomics (1998) 1.11
Rubinstein-Taybi syndrome caused by a De Novo reciprocal translocation t(2;16)(q36.3;p13.3). Am J Med Genet (2000) 1.11
Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat (1997) 1.11
Predictive diagnosis of myotonic dystrophy with flanking microsatellite markers. J Med Genet (1991) 1.10
Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia'. Acta Psychiatr Scand (2014) 1.10
Variation of CNV distribution in five different ethnic populations. Cytogenet Genome Res (2007) 1.10